Race/Ethnicity, Obesity, Health Related Behaviors and the Risk of Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial
Abstract
Purpose:
We examined risk factors for incident symptomatic benign prostate hyperplasia in 5,667 Prostate Cancer Prevention Trial placebo arm participants who were free of benign prostatic hyperplasia at baseline.
Materials and Methods:
During 7 years benign prostatic hyperplasia symptoms were assessed annually using the International Prostate Symptom Score and benign prostatic hyperplasia treatment was assessed quarterly by structured interview. Total benign prostatic hyperplasia was defined as receipt of treatment or report of 2 International Prostate Symptom Score values greater than 14. Severe benign prostatic hyperplasia was defined as treatment or 2 International Prostate Symptom Score values of 20 or greater. Weight and body circumferences were measured by trained staff and demographic health related characteristics were collected by questionnaire. Cox proportional hazards models were used to calculate the covariate adjusted relative hazards of benign prostatic hyperplasia developing.
Results:
The incidence of total benign prostatic hyperplasia was 34.4 per 1,000 person-years. The risk of total benign prostatic hyperplasia increased 4% (p <0.001) with each additional year of age. Risks for total benign prostatic hyperplasia were 41% higher for black (p <0.03) and Hispanic men (p <0.06) compared to white men, and for severe benign prostatic hyperplasia these increases were 68% (p <0.01) and 59% (p <0.03), respectively. Each 0.05 increase in waist-to-hip ratio (a measure of abdominal obesity) was associated with a 10% increased risk of total (p <0.003) and severe (p <0.02) benign prostatic hyperplasia. Neither smoking nor physical activity was associated with risk.
Conclusions:
Black race, Hispanic ethnicity and obesity, particularly abdominal obesity, are associated with increased benign prostatic hyperplasia risk. Weight loss may be helpful for the treatment or prevention of benign prostatic hyperplasia.
References
- 1 : Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study. J Urol2000; 163: 490. Link, Google Scholar
- 2 : Risk behaviours and benign prostatic hyperplasia. BJU Int2004; 93: 1241. Google Scholar
- 3 : Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men. Urology2002; 59: 877. Google Scholar
- 4 : Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men’s Health Study. Urology2003; 61: 1086. Google Scholar
- 5 : Relationship of serum sex-steroid hormones and prostate volume in African American men. Prostate2002; 53: 322. Google Scholar
- 6 : The influence of finasteride on the development of prostate cancer. N Engl J Med2003; 349: 215. Google Scholar
- 7 : Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status. BJU Int2000; 85: 665. Google Scholar
- 8 : Epidemiologic trends in the evaluation and treatment of lower urinary tract symptoms in elderly male Medicare patients from 1991 to 1995. J Urol1998; 160: 816. Link, Google Scholar
- 9 : Natural history of benign prostatic hyperplasia: appropriate case definition and estimation of its prevalence in the community. Urology1995; 46: 34. Google Scholar
- 10 : Incidence of surgically treated benign prostatic hypertrophy and of prostate cancer among blacks and whites in a prepaid health care plan. Am J Epidemiol1991; 134: 825. Google Scholar
- 11 : Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins. Epidemiology2006; 17: 419. Google Scholar
- 12 : Obesity and benign prostatic hyperplasia. Am J Epidemiol1994; 140: 989. Google Scholar
- 13 : Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol2001; 54: 935. Google Scholar
- 14 : Cigarette smoking, obesity, and benign prostatic hypertrophy: a prospective population-based study. Am J Epidemiol1992; 135: 500. Google Scholar
- 15 : Insulin-like growth factors and prostate cancer: a population-based case control study in China. Cancer Epidemiol Biomarkers Prev2001; 10: 421. Google Scholar
- 16 : Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol2002; 168: 599. Link, Google Scholar
- 17 : Risk factors for surgery for prostatic hypertrophy. Am J Epidemiol1992; 135: 974. Google Scholar
- 18 : The epidemiology of benign prostatic hyperplasia: a study in Greece. BJU Int1999; 84: 286. Google Scholar
